Apolipoprotein B

ApoB is a protein carried by every atherogenic lipoprotein particle — LDL, VLDL, IDL, and Lp(a) — with exactly one ApoB per particle. Measuring it therefore counts the number of artery-damaging particles directly, rather than the cholesterol they carry.

Atherosclerosis is driven by the number of ApoB-containing particles that enter the artery wall, not by cholesterol mass alone. ApoB is widely regarded as the most accurate single lipid measure of cardiovascular risk, and it can reveal risk that LDL-C misses — especially in insulin resistance, high triglycerides, or diabetes.

1. 1

   FoundationCardiovascular HealthThe best place to understand what actually prevents heart disease.
2. 2

   ConditionAtherosclerotic Cardiovascular DiseaseThe disease behind most heart attacks and strokes
3. 3

   Signal RecordOmega-3 Fatty AcidsFish Oil / EPA + DHA
4. 4

   Body SystemCardiovascularHeart function, blood pressure, and circulatory health.
5. 5

   BiomarkerLDL CholesterolThe primary lipid risk target

1. Measure it
2. Understand your result
3. See what raises and lowers it
4. Apply evidence-based interventions
5. Recheck on your review cadence

An orientation to how this topic is typically approached — not medical advice.

Higher ApoB means more atherogenic particles and greater lifetime cardiovascular risk. A high ApoB with a 'normal' LDL-C signals many small, cholesterol-poor particles — a discordance that reclassifies risk upward.

• Blood immunoassay (fasting not required)
• Often ordered alongside a standard lipid panel

The causal role of ApoB-containing lipoproteins in atherosclerosis is among the best-established findings in cardiovascular medicine, supported by genetics, large trials, and mechanism. Whether ApoB should replace LDL-C as the primary target is an area of active guideline discussion.

• 2018 ACC/AHA Guideline on the Management of Blood Cholesterol
• 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
• National Lipid Association recommendations

Sources are named authoritative guidelines and scientific bodies. Biomarker pages present established clinical context; calibrated evidence verdicts on specific interventions live in the linked Signal Records.